CLBS - Caladrius Biosciences - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Caladrius Biosciences's activity chart (see below) currently has 6 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from HC WAINWRIGHT on 06-Jun-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Nov-2018

Buy Since 20-Nov-2018

$18.5

Buy Since 22-May-2020

$6.57 (1527.91%)

Buy Since 15-Mar-2019

$5.57 (1295.35%)

Show more analysts

What is CLBS (Caladrius Biosciences) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CLBS (Caladrius Biosciences) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?

Joseph Pantginis has 23 price targets and 30 ratings on CLBS

Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?

Kumaraguru Raja with highest potential upside - $6.57

Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?

Joseph Pantginis with lowest potential downside - -$0